Clinical rationale for the use of various teraflex formulations in osteoarthrosis
The paper provides a rationale for using Teraflex with a manifest symptom-modifying effect in patients with osteoarthritis (OA). It is noted that the use of agents that are potentially able to modify cartilage metabolic processes attracts attention above all due to the possibility of achieving a per...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
IMA-PRESS LLC
2010-12-01
|
| Sarja: | Современная ревматология |
| Aiheet: | |
| Linkit: | https://mrj.ima-press.net/mrj/article/view/324 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|